Quest Diagnostics (NYSE:DGX) was upgraded by equities research analysts at EVA Dimensions from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, American Banking & Market News reports. Quest Diagnostics Inc (NYSE:DGX) shares after opening at $58.50 moved to $60.50 on last trade day and at the end of the day closed at $57.99. Company price to sales ratio in past twelve months was calculated as 1.18 and price to cash ratio as 45.28. Quest Diagnostics Inc (NYSE:DGX) showed a positive weekly performance of 3.91%.
Five Below Inc (NASDAQ:FIVE) surprised and encouraged at the same time when the discount retailer reported its fourth quarter results. Despite the brutal winter weather, the company exceeded earnings expectations. And as if that was not enough, the management went on to issue earnings estimate that flew past the projection of analysts. FIVE expects to report EPS in the range of $0.86 – $0.89 in the current fiscal year, a range which flies far above the $0.66 EPS estimation by analysts. Sales in the quarter were up 22 percent despite of the downtrodden weather. The results were surprising considering that the company had warned about its profit in December, a move that sent shares tumbling down from their historic high price levels. Five Below Inc (NASDAQ:FIVE) shares advanced 11.42% in last trading session and ended the day on $42.34. FIVE return on equity ratio is recorded as 34.70% and its return on assets is 14.10%. Five Below Inc (NASDAQ:FIVE) yearly performance is 6.20%.
Tenet Healthcare Corp (NYSE:THC) looks forward to achieving adjusted EBITDA in the range of $1.8 – $1.9 billion in the current year. In this guidance, the company announced that it is assuming favorable impact of between $50 and $100 million from its acquisition of Vanguard. Benefits from Vanguard are expected to start coming by the second quarter of the current fiscal year. Also, the company hopes to benefit from the Affordable Care Act (ACA) in the range of $50 – $100 million. Tenet Healthcare Corp (NYSE:THC) shares moved up 5.22% in last trading session and was closed at $40.93, while trading in range of $39.14-$41.64. Tenet Healthcare Corp (NYSE:THC) year to date performance is -2.83%.
Steelcase Inc. (NYSE:SCS) after successfully cracking the Americas market, the focus of the management at Steelcase, led by the new CEO, is to turnaround operations in Europe, Middle East and Africa, otherwise known as EMEA region. The CEO Jim Keane observed that as efficiency has helped them put the Americas market on solid grounds, they hope the same strategy will be able to boost business in EMEA, where their competitors are at loss on how to handle the new era in the markets. Steelcase Inc. (NYSE:SCS) weekly performance is 14.17%. On last trading day company shares ended up $16.28. Steelcase Inc. (NYSE:SCS) distance from 50-day simple moving average is 10.85%. Analysts mean target price for the company is $19.00.